Growth Metrics

Integra Lifesciences Holdings (IART) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $109.7 million.

  • Integra Lifesciences Holdings' Long-Term Deferred Tax rose 12422.76% to $109.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.7 million, marking a year-over-year increase of 12422.76%. This contributed to the annual value of $34.9 million for FY2024, which is 2421.22% down from last year.
  • Latest data reveals that Integra Lifesciences Holdings reported Long-Term Deferred Tax of $109.7 million as of Q3 2025, which was up 12422.76% from $102.9 million recorded in Q2 2025.
  • Integra Lifesciences Holdings' 5-year Long-Term Deferred Tax high stood at $109.7 million for Q3 2025, and its period low was $34.2 million during Q1 2024.
  • Moreover, its 5-year median value for Long-Term Deferred Tax was $51.8 million (2022), whereas its average is $58.9 million.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first skyrocketed by 310283.26% in 2021, then crashed by 4360.6% in 2022.
  • Integra Lifesciences Holdings' Long-Term Deferred Tax (Quarter) stood at $57.0 million in 2021, then fell by 19.24% to $46.0 million in 2022, then increased by 0.19% to $46.1 million in 2023, then dropped by 24.21% to $34.9 million in 2024, then soared by 214.2% to $109.7 million in 2025.
  • Its Long-Term Deferred Tax was $109.7 million in Q3 2025, compared to $102.9 million in Q2 2025 and $38.0 million in Q1 2025.